J Drugs Dermatol. 2024 Jun 1;23(6):418-422. doi: 10.36849/JDD.7657.
BACKGROUND: Microneedling has been shown to release growth factors, which improves the appearance of acne scars by itself and in combination with different therapy modalities. Combining microneedling with Chemical Reconstruction of Scarred Skin (CROSS) therapy using a 60% phenol and 0.2% croton oil combination results in a significant improvement of acne scarring. OBJECTIVE: To assess the safety and efficacy of combination treatments using microneedling in combination with CROSS therapy that contains 60% phenol and 0.2% croton preparation in patients with Fitzpatrick skin types III to V. Materials and Methods: Patients were treated over a 5-year period for atrophic acne scars using microneedling combined with CROSS. Most of the patients had combination atrophic scarring. High-quality before and after photographs were taken of the patients to assess the improvement in the scars. Results: Most of the patients (89.5%) had Fitzpatrick skin types IV through V. Analysis was done on a maximum of 3 microneedling sessions with 1 to 3 CROSS sessions. Photographic evaluation using the Global Aesthetic Improvement Scale showed an 18% grade-1 improvement and 81% grade-2 improvement. The Goodman and Baron Qualitative scar grading system showed a 62% grade-1 improvement and 38% grade-2 improvement. CONCLUSION: Combination treatments work best for atrophic scars. This is the first published report of using microneedling with a 60% phenol/0.2% croton oil combination. It proved to be very effective and safe in treating atrophic acne scars in Fitzpatrick skin types III to V, with minimal side effects and a quick recovery. J Drugs Dermatol. 2024;23(6):418-422. doi:10.36849/JDD.7657.
背景:微针已被证明能释放生长因子,这本身就能改善痤疮疤痕的外观,与不同的治疗方式结合使用效果更佳。将微针与使用 60%苯酚和 0.2%巴豆油的化学重建瘢痕皮肤疗法(CROSS)联合使用,可显著改善痤疮瘢痕。
目的:评估在 III 至 V 型 Fitzpatrick 皮肤患者中,使用包含 60%苯酚和 0.2%巴豆油的 CROSS 疗法与微针相结合的联合治疗的安全性和疗效。
材料与方法:在 5 年期间,使用微针联合 CROSS 治疗凹陷性痤疮瘢痕患者。大多数患者存在混合性凹陷性瘢痕。对患者进行高质量的治疗前后照片拍摄,以评估瘢痕改善情况。
结果:大多数患者(89.5%)为 IV 至 V 型 Fitzpatrick 皮肤。分析最多进行 3 次微针治疗和 1 至 3 次 CROSS 治疗。使用整体美学改善量表的照片评估显示 18%为 1 级改善,81%为 2 级改善。Goodman 和 Baron 定性瘢痕分级系统显示 62%为 1 级改善,38%为 2 级改善。
结论:联合治疗对凹陷性瘢痕效果最佳。这是首次报道使用包含 60%苯酚/0.2%巴豆油的微针联合疗法。在 III 至 V 型 Fitzpatrick 皮肤的患者中,它被证明对治疗凹陷性痤疮瘢痕非常有效且安全,副作用极小,恢复迅速。J 皮肤病药物杂志。2024;23(6):418-422。
doi:10.36849/JDD.7657.
J Cosmet Dermatol. 2014-9
J Cosmet Dermatol. 2021-11
J Cosmet Dermatol. 2018-6